Vir Biotechnology (VIR) Cash from Investing Activities (2018 - 2026)
Vir Biotechnology's Cash from Investing Activities came in at -$197.14 million for Q2 2026, compared with $56.46 million a year earlier.
Powered by 
Analysis
Vir Biotechnology (VIR) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Vir Biotechnology reported Cash from Investing Activities of -$58.21 million; for FY2025, it was $310.37 million, down 37.8% from FY2024.
- Going back by year, Cash from Investing Activities was $499.37 million in FY2024 (+203.3%), $164.63 million in FY2023, -$1.19 billion in FY2022 and -$140.81 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Cash from Investing Activities since Q3 2022.
- Year-over-year, Cash from Investing Activities increased in 1 of the last five quarters, with growth averaging 15.6%.
- Business Quant data shows VIR's Cash from Investing Activities at $11.84 million (Q1 2026), $86.65 million (Q4 2025) and $40.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn | -197.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -197.14 Mn |
| Mar 31, 2026 | 11.84 Mn |
| Dec 31, 2025 | 86.65 Mn |
| Sep 30, 2025 | 40.45 Mn |
| Jun 30, 2025 | 56.46 Mn |
| Mar 31, 2025 | 126.82 Mn |
| Dec 31, 2024 | 140.74 Mn |
| Sep 30, 2024 | 118.60 Mn |
| Jun 30, 2024 | 211.61 Mn |
| Mar 31, 2024 | 28.42 Mn |
| Dec 31, 2023 | -104.81 Mn |
| Sep 30, 2023 | -58.95 Mn |
| Jun 30, 2023 | 230.32 Mn |
| Mar 31, 2023 | 98.08 Mn |
| Dec 31, 2022 | -153.14 Mn |
| Sep 30, 2022 | -662.61 Mn |
| Jun 30, 2022 | -272.33 Mn |
| Mar 31, 2022 | -105.39 Mn |
| Dec 31, 2021 | -377.58 Mn |
| Sep 30, 2021 | 73.86 Mn |
API Access
Vir Biotechnology Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();